A copy number repeat polymorphism in the transactivation domain of the CEPBA gene is possibly associated with a protective effect against acquired CEBPA mutations: an analysis in 1135 patients with AML and 187 healthy controls.

Standard

A copy number repeat polymorphism in the transactivation domain of the CEPBA gene is possibly associated with a protective effect against acquired CEBPA mutations: an analysis in 1135 patients with AML and 187 healthy controls. / Schnittger, Susanne; Bacher, Ulrike; Eder, Christiane; Lohse, Peter; Haferlach, Claudia; Kern, Wolfgang; Haferlach, Torsten.

In: EXP HEMATOL, Vol. 39, No. 1, 1, 2011, p. 87-94.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

APA

Vancouver

Bibtex

@article{c4bea627a4304e22b45757e59b74f70c,
title = "A copy number repeat polymorphism in the transactivation domain of the CEPBA gene is possibly associated with a protective effect against acquired CEBPA mutations: an analysis in 1135 patients with AML and 187 healthy controls.",
abstract = "CEBPA-mutated normal karyotype acute myeloid leukemia (AML) has recently been included as a provisional entity in the World Health Organization classification. The CEBPA mutations are heterogeneous, including missense/nonsense base exchanges, frameshift mutations, and insertions/deletions being distributed throughout the gene. One of the genetic alterations within CEBPA (c.1175_1180dup; p.P194_H195dup) was later suggested to represent an inherited polymorphism. As this is not a simple single nucleotide polymorphism, but a six-base pair insertion that leads to a two amino acid elongation of the protein, functional implications cannot be excluded.",
author = "Susanne Schnittger and Ulrike Bacher and Christiane Eder and Peter Lohse and Claudia Haferlach and Wolfgang Kern and Torsten Haferlach",
year = "2011",
language = "Deutsch",
volume = "39",
pages = "87--94",
journal = "EXP HEMATOL",
issn = "0301-472X",
publisher = "Elsevier Inc.",
number = "1",

}

RIS

TY - JOUR

T1 - A copy number repeat polymorphism in the transactivation domain of the CEPBA gene is possibly associated with a protective effect against acquired CEBPA mutations: an analysis in 1135 patients with AML and 187 healthy controls.

AU - Schnittger, Susanne

AU - Bacher, Ulrike

AU - Eder, Christiane

AU - Lohse, Peter

AU - Haferlach, Claudia

AU - Kern, Wolfgang

AU - Haferlach, Torsten

PY - 2011

Y1 - 2011

N2 - CEBPA-mutated normal karyotype acute myeloid leukemia (AML) has recently been included as a provisional entity in the World Health Organization classification. The CEBPA mutations are heterogeneous, including missense/nonsense base exchanges, frameshift mutations, and insertions/deletions being distributed throughout the gene. One of the genetic alterations within CEBPA (c.1175_1180dup; p.P194_H195dup) was later suggested to represent an inherited polymorphism. As this is not a simple single nucleotide polymorphism, but a six-base pair insertion that leads to a two amino acid elongation of the protein, functional implications cannot be excluded.

AB - CEBPA-mutated normal karyotype acute myeloid leukemia (AML) has recently been included as a provisional entity in the World Health Organization classification. The CEBPA mutations are heterogeneous, including missense/nonsense base exchanges, frameshift mutations, and insertions/deletions being distributed throughout the gene. One of the genetic alterations within CEBPA (c.1175_1180dup; p.P194_H195dup) was later suggested to represent an inherited polymorphism. As this is not a simple single nucleotide polymorphism, but a six-base pair insertion that leads to a two amino acid elongation of the protein, functional implications cannot be excluded.

M3 - SCORING: Zeitschriftenaufsatz

VL - 39

SP - 87

EP - 94

JO - EXP HEMATOL

JF - EXP HEMATOL

SN - 0301-472X

IS - 1

M1 - 1

ER -